The aim of this study was to investigate the influence of intracoronary injection of mononuclear BM cells (mBMCs) on inflammatory mediators in swine with acute myocardial infarction (AMI) in two groups. Group 1 received the therapy immediately after AMI, but group 2 received it after 3 weeks. The levels of cytokines and heart functions, respectively, were examined 3 weeks after cell therapy. The serum levels of TNF-a and IL-8 were significantly lower than in the control group: in contrast, IL-10 was significantly elevated in the cell recipients, especially in group 1. TNF-a correlated with IL-8 between groups. The ventricular functions were significantly improved. These results show that although the intracoronary injection of mBMCs induces a marked short-term inflammatory response in the acute stage, mBMCs may play an anti-inflammatory role topically and systematically and early cell therapy may be preferable.
Introduction
Intracoronary transplantation of different cell populations has been used in acute myocardial infarction (AMI) with promising results. [1] [2] [3] [4] As expected by scientists, a major reservoir of adult autologous stem cells distal from the heart is the BM. 5, 6 Adequate regulation of signaling between the BM, the peripheral circulation and the infarcted myocardium is important in orchestrating the process of mobilization, homing, incorporation, survival, proliferation and the differentiation of stem cells that leads to myocardial regeneration. 7 Known as developmental plasticity, the implanted cells could differentiate into different cells of different lineages in ischemic myocardium. [8] [9] [10] All of the research that has been conducted emphasizes the amelioration of the heart function several months after cell therapy, [1] [2] [3] whereas the variations of cytokine and heart function during the acute phase have not been delineated. Evidence indicates that cytokines are involved in the pathogenesis of various inflammatory disorders. Systemic inflammatory responses to AMI are detrimental to heart function. [11] [12] [13] Cytokine profiles may have a role in deciphering the role of inflammation in the pathogenesis of coronary artery disease.
The aim of this study was to evaluate the change of cytokines in an AMI swine model after transplantation of mononuclear BM cells (mBMCs) and to investigate the optimal time of cell therapy.
Materials and methods
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996). Experimental protocols were approved by the Animal Use Subcommittee at the Peking University Health Science Center. In this study, Su Zhong swine weighing 35 kg were purchased from the Experimental Animal Center (Peking, China). We used thoroughbred animals obtained 3-5 days before the experiments were conducted. The animals were housed in air-conditioned rooms under conditions of constant temperature and humidity and with free access to food and water at all times. Proper analgesic, anesthetic and tranquilizing drugs were provided when needed to all experimental animals. The swine were pretreated with 100 mg of aspirin per day and fasted overnight before the experiments. After fasting and pre-operative antibiotic treatment, each pig was anesthetized with sodium pentobarbital (15 mg/kg) and intubated with a cuffed endotracheal tube. After shaving the surgical sites and cleansing with tincture of iodine, an electrocardiogram was obtained.
Preparation of donor cells of swine Bone marrow (40 ml) was aspirated from the iliac crest of each pig under local anesthesia 1 h before the experiment. The aspirates were heparinized, centrifuged at 800 g for 10 min at room temperature, and the serum layers were discarded. The cells were diluted 1:1 with PBS and layered over an equal volume of Lymphoprep (1.077 g/ml; Tianjin Haoyang Biological Manufacture Co., Tianjin, China) and later centrifuged at 800 g for 30 min. Mononuclear cells were recovered from the buffy coat at the gradient interface and washed twice with PBS (300 g for 5 min at room temperature). Mononuclear cells were stained with PKH26 (PKH26-GL Red Fluorescent Cell Linker Kit, SigmaAldrich, Inc., St Louis, MO, USA), a fluorescent dye used for in vivo cell tracking. Cell viability was determined by trypan blue exclusion after the staining procedure. The mean number of mononuclear cells was approximately 3.0-5.0 Â 10 7 and they were mixed with 8-10 ml of Dulbecco's Modified Eagle's Medium (DMEM; Gibco, Grand Island, NY, USA) for transplantation back to the same animal.
Swine myocardial infarction model and cell transfer
After local anesthesia with 2% lidocaine and arteriopuncture, a 6-7 French (Fr) arterial sheath was inserted through the right femoral artery and a 6 Fr coronary guiding catheter was inserted into the coronary ostium under fluoroscopic guidance. An experimental myocardial infarction (MI) was created by over-the-wire balloon occlusion (3.0 or 3.5 mm in diameter) for 90 min at 8-10 atm in the left anterior descending (LAD) artery just distal to the first diagonal branch. A coronary angiogram and electrocardiogram verified that the MI model had been established.
After an experimental MI was induced, the swine were divided randomly into two groups as follows: control 1 (C1), experimental group 1 (G1), control 2 (C2), and experimental group 2 (G2). All infusions were carried out through cardiac catheterization at two time points; in G1, cells were infused immediately subsequent to establishment of the AMI, and in G2, the cells were infused 3 weeks after the AMI was established. Those swine with AMI that did not receive mBMCs served as controls ( Figure 1 ).
In G1, immediately after the MI was induced, mBMCs were transplanted into the LAD using an over-the-wire balloon catheter placed within the LAD. With 4-6 atm pressure inflation in the balloon catheter, a 10 ml cell suspension (3.0-5.0 Â 10 7 cells) was infused over 5 min. Ballooning prevented cell backflow and at the same time produced a stop-flow beyond the site of the balloon inflation to facilitate high-pressure infusion of cells into the infarcted zone. This procedure prolonged the contact time for cellular migration. After the intracoronary delivery of mBMCs, coronary angiography was carried out to assess the patency of the coronary artery. In G2, 3 weeks after the MI was induced, the same administration was enforced with an over-the-wire balloon catheter placed just adjacent to the first diagonal branch.
After the experimental procedure, the left femoral artery was compressed to assure hemostasis for 10 min and the swine were returned to the animal quarters. Twenty-six swine were selected in the initial stage, but six animals were excluded owing to the development of ventricular fibrillation and other complications during the course of the study or immediately after a period of ischemia.
Cardiac function analysis
Filled with heparinized physiologic saline, the catheter was inserted into the left ventricle and its tail was connected to a pressure sensor and the bubbles were completely discharged. An MPA multichannel signal analytical system (Shanghai Alcott Biotech Co. Ltd, Shanghai, China) was conducted three (G1) and 6 weeks (G2) after MI in the swine. Left ventricular pressure (LVP) parameter tests and curves were recorded by a multipotent adult progenitor (MAP) system. The maximal left ventricular pressure (P max ), the maximal ascending derivative of the left ventricular pressure (dP/dt max ), the left ventricular pressure corresponding to maximal dP/dt (P@dP/dt max ) and the left ventricular end diastolic pressure (LVEDP) were calculated. The auricular and right jugular veins were cannulated for fluid infusion in swine.
Assay of cytokines in swine serum
Serum concentrations of IL-8, IL-10 and TNF-a were measured by using commercially available ELISA kits (Rapidbion West Hills, CA, USA) and absorbance was read at 450 nm. Results were expressed in pg/ml serum.
Statistical analysis of data
All data are expressed as the mean ± s.d. Statistical significances between groups were determined using Stata 7.0 with repeated measures of analysis of variance. Differences were considered significant when P was o0.05.
Results

Cardiac function analysis
For data processing, each parameter was calculated by an MPA multichannel signal analytical system. LVP and velocity variations were recorded. Hemodynamics data were obtained 3 weeks after cell therapy in C1 and G1 (C1-3w and G1-3w), 6 weeks after AMI, and 3 weeks after cell therapy in C2 and therapy G2 (C2-6w and G2-6w). Figure 2 represents the LVP and velocity curve in the two groups, C1 vs G1 and C2 vs G2; see Figure 2 .
Compared with the corresponding control group, P max and P@dP/dt max were significantly increased 3 weeks after cell therapy (G1-3w vs C1-3w, Po0.001 and G2-6w vs C2-6w, Po0.05) and dP/dt max (Po0.001). Compared with the corresponding control group, LVEDP was significantly decreased (G1-3w vs C1-3w, Po0.05 and G2-6w vs C2-6w, Po0.01). Between the two treatment groups at 3 weeks, there were differences in P max , P@dP/dt max and dP/dt max (I to K: G1 vs G2, Po0.05) and no differences in LVEDP (L: G1 vs G2, P40.05).
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The serum concentrations of cytokines The serum concentrations of IL-8, IL-10 and TNF-a after intracoronary mBMC therapy was determined by ELISA at each time point in the two groups. After intracoronary transplantation of mBMCs, the levels of TNF-a and IL-8 were significantly lower than the level in the control groups (Po0.05), and IL-10 was significantly elevated in swine that received cell therapy (Po0.05). The serum concentrations of TNF-a correlated with IL-8 (r ¼ 0.9231; P ¼ 0.0253) in the early group. This upregulation of IL-10 was detectable by the seventh day and peaked on the first day after transplantation. This phenomenon was observed in the two treatment groups. It is interesting that, although slightly elevated at 7 days, the levels of IL-8 and TNF-a persisted at a low level. The levels of IL-8 and TNF-a were significantly lower than the levels in the control groups 1 day after transplantation (Figures 3-5 ). Comparing G1 and C1, the IL-8 levels were very different (F ¼ 29.26, P ¼ 0.0010) and at each paired time point they were also different (F ¼ 15.24, P ¼ o0.0001). There were no interactions between each group and each time point (F ¼ 2.68, P ¼ 0.0523). Between G2 and C2, the IL-8 levels were not significantly different (F ¼ 0.35, P ¼ 0.05376). The IL-8 levels in each paired time point were also different (F ¼ 5.70, P ¼ 0.0017). There were no interactions in each group and at each time point (F ¼ 2.66, P ¼ 0.0532). Comparing G1 and G2, there were significant differences in IL-8 levels (F ¼ 32.48, P ¼ 0.0002) and at each time point (F ¼ 22.81, P ¼ 0.0092). There were interactions between groups and time points (F ¼ 3.89, P ¼ 0.0092); see Figure 3 .
Comparing G1 and C1, the IL-10 levels were different (F ¼ 42.79, P ¼ 0.0003) and also different (F ¼ 13.89, P ¼ o0.0001) at each paired time point. There were interactions between each group and each time point (F ¼ 27.68, P ¼ o0.0001). Comparing G2 and C2, the IL-10 levels were significantly different (F ¼ 50. 15 and the IL-10 levels were also different (F ¼ 11.71, P ¼ o0.0001) at each paired time point. There were interactions between each group and each time point (F ¼ 9.72, P ¼ o0.0001). Comparing G1 and G2, there was no difference (F ¼ 2.33, P ¼ 0.1580) in IL-10 levels, but there was a significant difference at each time point (F ¼ 58.74, P ¼ o0.0001). There were interactions between each group and each time point (F ¼ 11.43, P ¼ o0.0001); Figure 4 . Comparing G1 and C1, the TNF-a levels were very different (F ¼ 85.75, P ¼ o0.00001) and at each paired time point they were also different (F ¼ 30.68, P ¼ o0.0001). There were interactions between each group and each time point (F ¼ 6.43, P ¼ 0.0008). Comparing G2 and C2, the TNF-a levels were not significantly different (F ¼ 2.13, P ¼ 0.1879), but the IL-8 levels at each paired time point were different (F ¼ 8.89, P ¼ o0.0001). There were interactions between each group and each time point (F ¼ 4.99, P ¼ 0.0037). There is a significant difference in TNF-a at each time point (F ¼ 908.24, P ¼ o0.0001), and no difference between G1 and G2 (F ¼ 37.48, P ¼o0.0001). There were interactions between each group and each time point (F ¼ 12.35, P ¼o0.0001). (Figure 5 ).
Discussion
Our results show that after intracoronary transplantation of mBMCs, there is a significant decrease in the serum concentrations of TNF-a and IL-8, and an increase in IL-10 occurred in swine with AMI. The marked changes in cytokines occurred in the group in which cells were infused immediately after the AMI was induced; the changes in TNF-a, IL-10 and IL8 were of clinical significance. Within two treatments at two different time points, systolic parameters regarding cardiac function showed unexpected significant differences, indicating that the intracoronary administration of cells immediately after the onset of the MI was superior to cell therapy 3 weeks after AMI.
After AMI, systemic inflammatory responses are associated with an increase in plasma cytokines, such as TNF-a and IL-10, in the myocardium and blood. TNF-a is one kind of pro-inflammatory cytokine that can cause severe damage to cardiomyocytes and suppress cardiac function. 13 IL-10 is an anti-inflammatory cytokine that protects cardiac function through inhibition of TNF-a production. [14] [15] [16] During the course of a MI, IL-8 and TNF-a increase the degree of myocardial damage. 11, 12 Subsequently, when it comes to the curative effect of cell therapy, some researchers have established a number of methods to validate the differentiation and fusion of BM, as well as to interpret the beneficial results of their experimental findings. They also explained improvement as an endocrine or exocrine effect, or regarded progenitor cells as inflammatory cells when in the myocardium. 17 In the myocardium, monocyte-derived macrophages and mast cells may also produce cytokines and growth factors necessary for fibroblast proliferation and neovascularization, leading to effective repair and scar formation. 18 Generally, circulating mononuclear cells are an important source of inflammatory cytokines in the plasma and myocardium.
That mBMCs provoke an anti-inflammatory chain reaction in peripheral blood and local myocardium could explain the phenomenon that mBMC administration results in IL-10 elevation, and IL-8 and TNF-a reduction. At this stage, the expression of inhibitory cytokines, such as IL-10, may have a role in suppressing the acute inflammatory response that results in amelioration of the heart function.
In the natural state without intervention, when mBMCs or progenitor cells are stimulated by ischemia, mobilized by cytokines, and then enter the peripheral blood autonomously or compulsorily, what is the fate of these cells? There are many reports that the so-called stem cells must differentiate into some specific kinds of cells. 6 We simply want to report a certain change in cytokines after cell therapy, which we explain as an inflammatory or immune chain reaction. Actually, we do not study it after a common mechanism, such as ischemia, and remolding mechanism. What we try to do is to find out the triggers of the chain reaction, not to analyze or inspect the results.
The effects of cell therapy have been studied with interesting and conflicting results. Inflammatory responses after intracoronary injection of autologous mBMC are not clarified. In the autologous stem cell transplantation in acute myocardial infarction (ASTAMI) study, Lunde et al. stated that intracoronary transplantation of autologous mBMCs in the acute phase after AMI is feasible and seems safe in the short term. 19 In the ASTAMI substudy, it is reported that mBMC administration 5-8 days after percutaneous coronary intervention (PCI) significantly improved exercise time and heart rate responses to exercise compared with the control group. Recently, Solheim et al. 21 investigated the influence of intracoronary injection of mBMC on inflammatory mediators in patients with AMI in the ASTAMI trial. They found that the intracoronary injection of mBMCs in patients with AMI induces a marked short-term inflammatory response, and that the levels of IL-6 and the expression of TNF-a mRNA increased significantly in the mBMC group compared with the control group. However, slightly reduced inflammation was observed after 3 months, which may have implications for the timing of SCT in AMI.
In our study, it should be pointed out that cardiac catheterization-based AMI mimics human AMI in a less traumatic manner. So far as this ischemic model is concerned, it seems that it resembles acute coronary syndromes, different from the ischemic model established by ligating the LAD.
In conclusion, mBMCs are best indicated at an acute stage to limit the inflammatory reaction that may have implications for the timing of cell therapy in AMI. To further our research, we have developed a protocol to probe the interrelation between mBMCs and regulatory T cells.
